Antibody therapeutics are a dominating feature of the current drug development landscape, but increasing costs and time-consuming workflows represent major barriers to their discovery and development.

This article is based on a poster originally authored by Maryam Ahmadi, Elena Shvets, Frank Gesellchen, Jitender Bisht, Joshua Stewart, Manju Namdeo, Marco Stefano Torrisi, Sophie Davies, and Richard ...

Slingshot Biosciences (“Slingshot”) today announced two additions to its TruCytes™ cell mimic product line designed to accelerate cell therapy and stem cell research, development, and manufacturing ...